{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T11:55:48Z","timestamp":1777722948357,"version":"3.51.4"},"reference-count":78,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.revmed.2010.08.005","type":"journal-article","created":{"date-parts":[[2010,9,21]],"date-time":"2010-09-21T04:42:32Z","timestamp":1285044152000},"page":"552-559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Manifestations syst\u00e9miques et auto-immunes des syndromes my\u00e9lodysplasiques"],"prefix":"10.1016","volume":"32","author":[{"given":"O.","family":"Fain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Stirnemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Fenaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2010.08.005_bib0005","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/sj.bjc.6604935","article-title":"Risks of myeloid malignancies in patients with auto-immune conditions","volume":"100","author":"Anderson","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.revmed.2010.08.005_bib0010","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J","article-title":"An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155\u00a0patients","volume":"43","author":"Reinhold-Keller","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2010.08.005_bib0015","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/1529-0131(199808)41:8<1493::AID-ART21>3.0.CO;2-5","article-title":"Cytogenetic abnormalities and therapy-related myelodysplastic syndromes in rheumatic disease","volume":"41","author":"McCarthy","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2010.08.005_bib0020","first-page":"691","article-title":"Secondary myelodysplastic syndromes following treatment with azathioprine are associated with aberrations of chromosome 7","volume":"90","author":"Knipp","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.revmed.2010.08.005_bib0025","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3899\/jrheum.090834","article-title":"Azathioprine: association with therapy-related myelodysplastic syndrome and acute myeloid leukemia","volume":"37","author":"Kwong","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0030","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1080\/1042819021000016186","article-title":"Auto-immune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia","volume":"43","author":"Saif","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.revmed.2010.08.005_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000046525","article-title":"Immunohematological findings in myelodysplastic syndrome","volume":"105","author":"Novaretti","year":"2001","journal-title":"Acta Haematol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0040","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0248-8663(01)00367-8","article-title":"My\u00e9lodysplasies et maladies syst\u00e9miques\u00a0: une association non fortuite","volume":"22","author":"Berthier","year":"2001","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2010.08.005_bib0045","first-page":"721","article-title":"Rheumatic manifestations in myelodysplastic syndromes","volume":"18","author":"Castro","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0050","first-page":"213","article-title":"Immunological abnormalities in myelodysplastic syndromes","volume":"22","author":"Okamoto","year":"1998","journal-title":"Ryoikibetsu Shokogun Shirizu"},{"key":"10.1016\/j.revmed.2010.08.005_bib0055","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2141.1995.tb05310.x","article-title":"Paraneoplastic auto-immune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy","volume":"91","author":"Enright","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/rheumatology\/39.4.417","article-title":"Prevalence of rheumatic manifestations and antineutrophil cytoplasmic antibodies in haematological malignancies. A prospective study","volume":"39","author":"Hamidou","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2010.08.005_bib0065","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.revmed.2005.06.012","article-title":"Manifestations immunes associ\u00e9es aux syndromes my\u00e9lodysplasiques. \u00c9tude prospective de 40\u00a0patients","volume":"26","author":"Bouali","year":"2005","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2010.08.005_bib0070","first-page":"538","article-title":"Association maladies syst\u00e9miques et syndromes my\u00e9lodysplasiques. \u00c9tude r\u00e9trospective portant sur 14\u00a0observations","volume":"32","author":"Roy-Peaud","year":"2003","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2010.08.005_bib0075","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/ard.2003.012948","article-title":"Auto-immune manifestations in human myelodysplasia: a positive correlation with interferon regulatory factor-1 (IRF-1) expression","volume":"63","author":"Giannouli","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2010.08.005_bib0080","first-page":"486","article-title":"Vascularite et cancer\u00a0: 14\u00a0cas","volume":"142","author":"Fain","year":"1991","journal-title":"Ann Med Interne"},{"key":"10.1016\/j.revmed.2010.08.005_bib0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/sarh.2001.27717","article-title":"Systemic medium-size vessel vasculitis associated with chronic myelomonocytic leukaemia","volume":"31","author":"Hamidou","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2010.08.005_bib0090","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/ard.59.5.390","article-title":"Systemic vasculitis with bilateral perirenal haemorrhage in chronic myelomonocytic leukaemia","volume":"59","author":"Aslangul-Castier","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2010.08.005_bib0095","first-page":"S436","article-title":"Vasculitides and cancers: 60\u00a0cases","volume":"50","author":"Fain","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2010.08.005_bib0100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0190-9622(92)70003-X","article-title":"Erythema elevatum diutinum: a clinical and histopathologic study of 13\u00a0patients","volume":"26","author":"Yiannias","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2133.1994.tb08467.x","article-title":"Simultaneous occurrence of two rare cutaneous markers of poor prognosis in myelodysplastic syndrome: erythema elevatum diutinum and specific lesions","volume":"131","author":"Aractingi","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0110","first-page":"731","article-title":"Association of myelodysplastic syndrome and relapsing polychondritis: further evidence","volume":"9","author":"Hebbar","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2010.08.005_bib0115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.7326\/0003-4819-104-1-74","article-title":"Relapsing polychondritis. Survival and predictive role of early disease manifestations","volume":"104","author":"Michet","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2010.08.005_bib0120","first-page":"1208","article-title":"Myelodysplasia and relapsing polychondritis","volume":"22","author":"Piette","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005792-200105000-00003","article-title":"Dermatologic manifestations of relapsing polychondritis. A study of 200\u00a0cases at a single center","volume":"80","author":"Franc\u00e8s","year":"2001","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2010.08.005_bib0130","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/0002-9343(87)90229-4","article-title":"Sweet's syndrome and malignancy","volume":"82","author":"Cohen","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2010.08.005_bib0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.1989.tb00217.x","article-title":"Acute febrile neutrophilic dermatosis (Sweet's syndrome) in association with myelodysplastic syndromes: a report of three cases and a review of the literature","volume":"73","author":"Soppi","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0140","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1046\/j.1365-2133.2000.03912.x","article-title":"Association of acute neutrophilic dermatosis and myelodysplastic syndrome with (6;9) chromosome translocation: a case report and review of the literature","volume":"143","author":"Megarbane","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0150","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/archderm.142.9.1170","article-title":"Chronic recurrent lymphocytic Sweet syndrome as a predictive marker of myelodysplasia: a report of 9\u00a0cases","volume":"142","author":"Vignon-Pennamen","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0155","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2141.1993.tb08668.x","article-title":"Sweet's syndrome associated with G-CSF","volume":"85","author":"Paydas","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0160","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2141.1994.tb04799.x","article-title":"Sweet's syndrome during therapy with granulocyte colony-stimulating factor in a patient with aplastic anaemia","volume":"86","author":"Fukutoku","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0165","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-2141.1993.tb03083.x","article-title":"Sweet's syndrome associated with myelodysplasia: possible role of cytokines in the pathogenesis of the disease","volume":"84","author":"Reuss-Borst","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0170","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s10156-003-0254-6","article-title":"Successful treatment of pyoderma gangrenosum that developed in a patient with myelodysplastic syndrome","volume":"9","author":"Yamauchi","year":"2003","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.revmed.2010.08.005_bib0175","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0049-0172(92)90035-C","article-title":"Seronegative inflammatory arthritis in the myelodysplastic syndromes","volume":"21","author":"George","year":"1992","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2010.08.005_bib0180","first-page":"11","article-title":"Manifestations rhumatologiques associ\u00e9es aux syndromes my\u00e9lodysplasiques et my\u00e9loprolif\u00e9ratifs","volume":"59","author":"Pajus","year":"1992","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"10.1016\/j.revmed.2010.08.005_bib0185","first-page":"1357","article-title":"An association of polymyalgia rheumatica with myelodysplastic syndromes","volume":"21","author":"Kohli","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0190","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s100670200081","article-title":"Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship?","volume":"21","author":"Espinosa","year":"2002","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0195","first-page":"1649","article-title":"Rheumatic manifestations in patients with myelodysplastic and myeloproliferative diseases","volume":"21","author":"Kuzmich","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0200","first-page":"792","article-title":"Polymyalgia rheumatica in patients with myelodysplastic syndromes","volume":"23","author":"Hubscher","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0205","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/rheumatology\/35.5.496","article-title":"Polymyalgia rheumatica as the rheumatological manifestation of myelodysplastic syndrome in a Chinese patient","volume":"35","author":"Mok","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0210","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0609.1995.tb00231.x","article-title":"Immune-mediated complications in patients with myelodysplastic syndromes: clinical and cytogenetic features","volume":"55","author":"Billstrom","year":"1995","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0215","first-page":"217","article-title":"Maladie de Horton et syndrome my\u00e9lodysplasique associ\u00e9s \u00e0 des manifestations cutan\u00e9es inhabituelles","volume":"119","author":"Bensaid","year":"1992","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0220","first-page":"95","article-title":"Joint manifestations in myelodysplastic syndromes. A report of three cases presenting as polymyalgia rheumatica","volume":"64","author":"Berthelot","year":"1997","journal-title":"Rev Rhum Engl Ed"},{"key":"10.1016\/j.revmed.2010.08.005_bib0225","first-page":"685","article-title":"Temporal arteritis masquerading as chronic myelomonocytic leukemia","volume":"21","author":"Rizos","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0230","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/rheumatology\/26.6.458","article-title":"Lymphoreticular malignancy and monoclonal gammopathy presenting as polymyalgia rheumatica","volume":"26","author":"Kalra","year":"1987","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0235","unstructured":"Merlet V. Pr\u00e9valence du cancer chez 75\u00a0patients porteur d\u2019une maladie de Horton et\/ou une pseudopolyarthrite rhizom\u00e9lique. \u00c9tude r\u00e9trospective de 1987\u00a0\u00e0 1997\u00a0en m\u00e9decine interne. Clermont-Ferrand: Th\u00e8se de m\u00e9decine; 1998."},{"key":"10.1016\/j.revmed.2010.08.005_bib0240","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/10428190109097683","article-title":"Trisomy 8\u00a0involved in myelodysplastic syndromes as a risk factor for intestinal ulcers and thrombosis: Beh\u00e7et's syndrome","volume":"42","author":"Kimura","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.revmed.2010.08.005_bib0245","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/ajmg.a.32756","article-title":"Constitutional trisomy 8\u00a0and Beh\u00e7et syndrome","volume":"149A","author":"Becker","year":"2009","journal-title":"Am J Med Genet A"},{"issue":"4\u00a0Suppl.\u00a038","key":"10.1016\/j.revmed.2010.08.005_bib0250","first-page":"S108","article-title":"Beh\u00e7et's disease associated with trisomy 8\u00a0in a male Caucasian patient from Great Britain: a case report","volume":"23","author":"Kuttikat","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0255","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/pbc.21075","article-title":"Myelodysplastic syndrome with trisomy 8\u00a0associated with Beh\u00e7et syndrome: an immunologic link to a karyotypic abnormality","volume":"50","author":"Thachil","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.revmed.2010.08.005_bib0260","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00277-003-0819-6","article-title":"Resolution of Behcet's disease after HLA-mismatched unrelated cord blood transplantation for myelodysplastic syndrome","volume":"83","author":"Tomonari","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0265","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/10428199509059648","article-title":"Glomerular injury in chronic myelomonocytic leukemia","volume":"18","author":"Morschhauser","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.revmed.2010.08.005_bib0270","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/(SICI)1096-8652(199903)60:3<200::AID-AJH6>3.0.CO;2-0","article-title":"Myelodysplastic syndromes with nephrotic syndrome","volume":"60","author":"Saitoh","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0275","doi-asserted-by":"crossref","first-page":"661","DOI":"10.7326\/0003-4819-117-8-661","article-title":"The association between the myelodysplastic syndromes and Crohn disease","volume":"117","author":"Eng","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2010.08.005_bib0280","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000262292","article-title":"Pulmonary alveolar proteinosis as a terminal complication in a case of myelodysplastic syndrome with idic(20q-)","volume":"123","author":"Xue","year":"2010","journal-title":"Acta Haematol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0285","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.coi.2009.09.004","article-title":"Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages","volume":"21","author":"Trapnell","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0290","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0165-4608(02)00652-0","article-title":"Late appearance of t(1;19)(q11;q11) in myelodysplastic syndrome associated with dysplastic eosinophilia and pulmonary alveolar proteinosis","volume":"139","author":"Ando","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.revmed.2010.08.005_bib0295","first-page":"150","article-title":"Immunological abnormalities in myelodysplastic syndromes","volume":"33","author":"Hamblin","year":"1996","journal-title":"Semin Hematol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0300","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000083454","article-title":"Auto-immune disorders in two patients with myelodysplastic syndrome and 5q deletion","volume":"113","author":"Giagounidis","year":"2005","journal-title":"Acta Haematol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0305","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000072413","article-title":"Cyclosporine A in the treatment of a patient with immune thrombocytopenia accompanied by myelodysplastic syndrome and nephrotic syndrome","volume":"110","author":"Park","year":"2003","journal-title":"Acta Haematol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0310","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/096120339400300305","article-title":"Acute sideroblastic anemia in active systemic lupus erythematosus","volume":"3","author":"Jimenez-Balderas","year":"1994","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2010.08.005_bib0315","first-page":"322","article-title":"Auto-immune myelodysplasias","volume":"28","author":"Miescher","year":"1991","journal-title":"Semin Hematol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0320","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00277-002-0539-3","article-title":"Myelodysplastic syndrome complicated by auto-immune hemolytic anemia: remission of refractory anemia following mycophenolate mofetil","volume":"81","author":"Lin","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0325","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0301-472X(02)00968-2","article-title":"Autologous lymphocytes inhibit haemopoiesis in long-term culture in patients with myelodysplastic syndrome","volume":"30","author":"Baumann","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0330","first-page":"5","article-title":"Immune-mediated bone marrow failure syndromes of progenitor and stem cells: molecular analysis of cytotoxic T cell clones","volume":"45","author":"Maciejewski","year":"2007","journal-title":"Folia Histochem Cytobiol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0335","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1182\/blood-2004-05-2017","article-title":"Preferential suppression of trisomy 8\u00a0compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8\u00a0myelodysplastic syndrome","volume":"106","author":"Sloand","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2010.08.005_bib0340","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.leukres.2008.03.019","article-title":"A case of myelodysplastic syndrome associated with CD14(+)CD56(+) monocytosis, expansion of NK lymphocytes and defect of HLA-E expression","volume":"33","author":"Ruggiero","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.revmed.2010.08.005_bib0345","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0145-2126(01)00083-2","article-title":"T cell expansion in myelodysplastic syndrome: evidence for an auto-immune process","volume":"25","author":"Epperson","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.revmed.2010.08.005_bib0350","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.leukres.2004.06.001","article-title":"Myelodysplastic syndrome: an example of misguided immune surveillance?","volume":"28","author":"Barrett","year":"2004","journal-title":"Leuk Res"},{"key":"10.1016\/j.revmed.2010.08.005_bib0355","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/j.seminhematol.2007.11.006","article-title":"The role of the immune system in myelodysplasia: implications for therapy","volume":"45","author":"Sloand","year":"2008","journal-title":"Semin Hematol"},{"key":"10.1016\/j.revmed.2010.08.005_bib0360","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1182\/blood-2005-12-4769","article-title":"Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype","volume":"108","author":"Pellagatti","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2010.08.005_bib0365","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1182\/blood-2005-05-1884","article-title":"Interferon-gamma-induced gene expression in CD34\u00a0cells: identification of pathologic cytokine-specific signature profiles","volume":"107","author":"Zeng","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2010.08.005_bib0370","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1182\/blood-2005-05-1989","article-title":"NF-kappaB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome","volume":"107","author":"Braun","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2010.08.005_bib0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10428190009054877","article-title":"Excessive apoptosis in low risk myelodysplastic syndromes (MDS)","volume":"40","author":"Parker","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.revmed.2010.08.005_bib0380","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1038\/sj.onc.1210043","article-title":"Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia","volume":"26","author":"Carvalho","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.revmed.2010.08.005_bib0385","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1182\/blood-2007-01-067546","article-title":"CD4+CD25+high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS)","volume":"110","author":"Kordasti","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2010.08.005_bib0390","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/leu.2008.333","article-title":"Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS)","volume":"23","author":"Kotsianidis","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2010.08.005_bib0395","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3324\/haematol.11812","article-title":"Activation of cytotoxic T-cell receptor gammadelta T lymphocytes in response to specific stimulation in myelodysplastic syndromes","volume":"93","author":"Kiladjian","year":"2008","journal-title":"Haematologica"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866310008829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866310008829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:29:02Z","timestamp":1759336142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866310008829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":78,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0248866310008829"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2010.08.005","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Manifestations syst\u00e9miques et auto-immunes des syndromes my\u00e9lodysplasiques","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2010.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}